VIEMED HEALTHCARE INC

For the period ended Dec 31, 2023. Filed Mar 6, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 6, 2024

VMD$8.98+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Income and Comprehensive Income

VIEMED HEALTHCARE, INC.CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(Expressed in thousands of U.S. Dollars, except share and per share amounts)

	Year Ended December 31,
	Note	2023	2022
Revenue	2	$183,008	$138,832
Cost of revenue		70,225	54,152
Gross profit		$112,783	$84,680
Operating expenses
Selling, general and administrative		87,884	68,161
Research and development		2,782	2,696
Stock-based compensation	8	5,849	5,202
Depreciation and amortization		1,391	1,012
Loss on disposal of property and equipment		645	346
Other income, net		(98)	(989)
Income from operations		$14,330	$8,252
Non-operating income and expenses
Income from equity method investments		485	935
Interest expense, net	6	(424)	(197)
Net income before taxes		14,391	8,990
Provision for income taxes	10	4,148	2,768
Net income		$10,243	$6,222
Other comprehensive income
Change in unrealized gain/loss on derivative instruments, net of tax		—	278
Other comprehensive income		$—	$278
Comprehensive income		$10,243	$6,500
Net income per share
Basic	11	$0.27	$0.16
Diluted	11	$0.25	$0.16
Weighted average number of common shares outstanding:
Basic	11	38,354,071	38,655,403
Diluted	11	40,378,922	39,807,434

See accompanying notes to the consolidated financial statements
Page	F-4

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.